Page last updated: 2024-10-25

cimetidine and Hepatoerythropoietic Porphyria

cimetidine has been researched along with Hepatoerythropoietic Porphyria in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanigawa, K1
Yamashita, S1
Nakata, K1
Nagataki, S1
Yamamoto, S1
Hirano, Y1
Horie, Y1

Other Studies

2 other studies available for cimetidine and Hepatoerythropoietic Porphyria

ArticleYear
Cimetidine in erythropoietic protoporphyria.
    The American journal of gastroenterology, 1994, Volume: 89, Issue:5

    Topics: Cimetidine; Erythrocytes; Humans; Porphyria, Hepatoerythropoietic; Protoporphyrins

1994
Cimetidine reduces erythrocyte protoporphyrin in erythropoietic protoporphyria.
    The American journal of gastroenterology, 1993, Volume: 88, Issue:9

    Topics: Aged; Cimetidine; Erythrocytes; Female; Humans; Porphyria, Hepatoerythropoietic; Protoporphyrins

1993